Matching trials
2,411 results
- MASCIIndependent statistical analysis of Allogeneic SCT Of Pts With SCID And Other Primary Immunodeficiency Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- MATOCSSIndependent statistical analysis of Mepolizumab As a Steroid-sparing Treatment Option in the Churg Strauss Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Mature B-Cell Lymphoma And Leukemia Study III: Complete Statistical AnalysisIndependent statistical analysis of Mature B-Cell Lymphoma And Leukemia Study III: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01046825).
- Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation: Complete Statistical AnalysisIndependent statistical analysis of Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Maximizing Analgesia to Reduce Pain in Knee Osteoarthritis: Complete Statistical AnalysisIndependent statistical analysis of Maximizing Analgesia to Reduce Pain in Knee Osteoarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03098563).
- McCAVEIndependent statistical analysis of A Study Comparing the Efficacy and Safety of Vanucizumab and FOLFOX With Bevacizumab and FOLFOX in Participants With Untreated Metastatic Colorectal Cancer: primary endpoint results, effect estimate with…
- MDX-010 in Treating Patients With Stage IV Pancreatic Cancer That Cannot Be Removed By Surgery: Complete Statistical AnalysisIndependent statistical analysis of MDX-010 in Treating Patients With Stage IV Pancreatic Cancer That Cannot Be Removed By Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Measuring the Amount of Methadone or Morphine in the Blood of Neonates, Infants & Children After Cardiac Surgery.: Complete Statistical AnalysisIndependent statistical analysis of Measuring the Amount of Methadone or Morphine in the Blood of Neonates, Infants & Children After Cardiac Surgery.: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Mechanisms of Hypoglycemia Associated Autonomic Failure: Complete Statistical AnalysisIndependent statistical analysis of Mechanisms of Hypoglycemia Associated Autonomic Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00678145).
- Mechanisms of Refractory Hypertension (Reserpine): Complete Statistical AnalysisIndependent statistical analysis of Mechanisms of Refractory Hypertension (Reserpine): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03223272).
- MEDI8897 Ph2bComplete statistical analysis of the randomized phase 2 MEDI8897 Ph2b trial evaluating MEDI8897 for prevention of medically attended RSV lower respiratory tract infection in healthy preterm infants.
- Medications for Stopping Cocaine Dependence and Preventing Relapse: Complete Statistical AnalysisIndependent statistical analysis of Medications for Stopping Cocaine Dependence and Preventing Relapse: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00218023).
- MEK InhibitorIndependent statistical analysis of MEK Inhibitor PD-0325901 Trial in Adolescents and Adults With NF1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02096471).
- MEK Inhibitor AZD6244 in Treating Patients With Stage III or Stage IV Melanoma: Complete Statistical AnalysisIndependent statistical analysis of MEK Inhibitor AZD6244 in Treating Patients With Stage III or Stage IV Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MEK Inhibitor MSC1936369B Plus FOLFIRI in Second Line K-Ras Mutated Metastatic Colorectal Cancer (mCRC): Complete Statistical AnalysisIndependent statistical analysis of MEK Inhibitor MSC1936369B Plus FOLFIRI in Second Line K-Ras Mutated Metastatic Colorectal Cancer (mCRC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- MELODY-1Independent statistical analysis of MELODY-1, a randomized phase 2 study of macitentan versus placebo in subjects with combined pre- and post-capillary pulmonary hypertension due to left ventricular dysfunction, including its primary endpoint,…
- Melphalan and Panobinostat (LBH589) for the Treatment of Patients With Recurrent Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Melphalan and Panobinostat (LBH589) for the Treatment of Patients With Recurrent Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MERLINIndependent statistical analysis of A Trial of Bardoxolone Methyl in Patients With CKD at Risk of Rapid Progression (MERLIN): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Metformin for the Prevention of Oral Cancer in Patients With Oral Leukoplakia or Erythroplakia: Complete Statistical AnalysisIndependent statistical analysis of Metformin for the Prevention of Oral Cancer in Patients With Oral Leukoplakia or Erythroplakia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Metformin Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery: Complete Statistical AnalysisIndependent statistical analysis of Metformin Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01433913).
- Metformin in Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of Metformin in Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02252081).
- Metformin in Non Small Cell Lung Cancer (NSCLC): Complete Statistical AnalysisIndependent statistical analysis of Metformin in Non Small Cell Lung Cancer (NSCLC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02285855).
- Methadone vs Magnesium in Spinal Fusion: Complete Statistical AnalysisIndependent statistical analysis of Methadone vs Magnesium in Spinal Fusion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01795495).
- Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Methotrexate, Vincristine, Pegylated L-Asparaginase and Dexamethasone (MOAD) in Acute Lymphoblastic Leukemia (ALL) Salvage: Complete Statistical AnalysisIndependent statistical analysis of Methotrexate, Vincristine, Pegylated L-Asparaginase and Dexamethasone (MOAD) in Acute Lymphoblastic Leukemia (ALL) Salvage: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- METROIndependent statistical analysis of Metformin and Carbohydrate Restriction With Platinum Based Chemotherapy In Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NS-NSCLC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- MGC018 With or Without MGA012 in Advanced Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of MGC018 With or Without MGA012 in Advanced Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03729596).
- MgPOEMIndependent statistical analysis of Magnesium for Peroral Endoscopic Myotomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04638881).
- MGTA-456 in Patients With Inherited Metabolic Disorders Undergoing Hematopoietic Stem Cell Transplantation (HSCT): Complete Statistical AnalysisIndependent statistical analysis of MGTA-456 in Patients With Inherited Metabolic Disorders Undergoing Hematopoietic Stem Cell Transplantation (HSCT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection: Complete Statistical AnalysisIndependent statistical analysis of Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02589847).
- Microscopic Fluorescence-guided Vestibular Schwannoma Resection Using Fluorescein Sodium and YELLOW 560: Complete Statistical AnalysisIndependent statistical analysis of Microscopic Fluorescence-guided Vestibular Schwannoma Resection Using Fluorescein Sodium and YELLOW 560: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- MiDME2Independent statistical analysis of Dextromethorphan for Diabetic Macular Edema: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01441102).
- Midostaurin and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia and FLT3 Mutation: Complete Statistical AnalysisIndependent statistical analysis of Midostaurin and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia and FLT3 Mutation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Milk Thistle in Pathological Gambling: Complete Statistical AnalysisIndependent statistical analysis of Milk Thistle in Pathological Gambling: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02337634).
- MINDIndependent statistical analysis of Melatonin As A Novel Neuroprotectant In Preterm Infants- Dosage Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00649961).
- MiniCliniIndependent statistical analysis of Reduced Intensity Conditioning Using CD3+/CD19+ Depletion for Non Malignant Transplantable Diseases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- MIRACLEA detailed statistical analysis of the randomized phase 2 MIRACLE trial evaluating everolimus with goserelin and letrozole in patients with metastatic breast cancer, including trial design, progression-free survival, planned statistical methods, interpretation,…
- MIRNAIndependent statistical analysis of Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04321031).
- miRNAs, Suicide, and Ketamine – Plasma Exosomal microRNAs as Novel Biomarkers for Suicidality and Treatment Outcome: Complete Statistical AnalysisIndependent statistical analysis of miRNAs, Suicide, and Ketamine - Plasma Exosomal microRNAs as Novel Biomarkers for Suicidality and Treatment Outcome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Mission Connect Mild Traumatic Brain Injury (TBI) Integrated Clinical Protocol: Complete Statistical AnalysisIndependent statistical analysis of Mission Connect Mild Traumatic Brain Injury (TBI) Integrated Clinical Protocol: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01013870).
- MISTIEIndependent statistical analysis of Minimally Invasive Surgery and rtPA for Intracerebral Hemorrhage Evacuation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00224770).
- MitoCKDIndependent statistical analysis of Mitochondria and Chronic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03177798).
- MK-7625A Plus Metronidazole Versus Meropenem in Pediatric Participants With Complicated Intra-Abdominal Infection (cIAI) (MK-7625A-035): Complete Statistical AnalysisIndependent statistical analysis of MK-7625A Plus Metronidazole Versus Meropenem in Pediatric Participants With Complicated Intra-Abdominal Infection (cIAI) (MK-7625A-035): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- MLN8237 for Treatment of Participants With Ovarian, Fallopian Tube, or Peritoneal Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of MLN8237 for Treatment of Participants With Ovarian, Fallopian Tube, or Peritoneal Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- MND-ADA Transduction of CD34+ Cells From Children With ADA-SCID: Complete Statistical AnalysisIndependent statistical analysis of MND-ADA Transduction of CD34+ Cells From Children With ADA-SCID: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00794508).
- Mocetinostat (MGCD0103) Plus Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Hodgkin Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Mocetinostat (MGCD0103) Plus Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Hodgkin Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Mod-NalIndependent statistical analysis of Modafinil and Naltrexone to Reduce Cocaine and Alcohol Dependence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00142818).
- Modeling Stress-precipitated Smoking Behavior for Medication Development: Complete Statistical AnalysisIndependent statistical analysis of Modeling Stress-precipitated Smoking Behavior for Medication Development: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00773357).
- Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Transplant-Eligible Patients With Mantle Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Transplant-Eligible Patients With Mantle Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Modular Study to Evaluate CT7001 Alone in Cancer Patients With Advanced Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Modular Study to Evaluate CT7001 Alone in Cancer Patients With Advanced Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…